Side Effects of Coronary Stenting such as Severe Coronary Stenosis and Multiple Coronary Chronic Total Occlusions in Elderly Patients via Induced Proinflammatory and Prooxidative Stress

Table 3

Multivariate-adjusted categorical regression analysis for the biomarkers as risk factors of SOVS, OVO, TVO, and MVO.

	SOVS	value	OVO	value	TVO	value	MVO	value
	OR (95% CI)		OR (95% CI)		OR (95% CI)		OR (95% CI)
TNF-α (ng/L)	1.94 (1.87-1.99)	0.04	1.71 (1.18-2.68)	0.02	1.38 (1.12-1.36)	0.003	1.53 (1.29-1.81)	<0.001
TLR4 (MFI)	1.26 (1.14-1.43)	0.04	1.98 (1.74-2.24)	0.03	1.80 (1.20-2.79)	0.02	3.62 (1.82-7.31)	<0.001
ACR (nmol/mL)	1.91 (1.81-2.23)	0.03	1.86 (1.24-3.19)	0.02	2.50 (1.39-4.62)	0.01	3.35 (1.56-7.14)	<0.001
MDA (nmol/L)	1.89 (1.25-3.17)	0.02	1.37 (1.26-1.69)	0.004	2.10 (1.39-2.97)	0.001	3.65 (1.95-7.65)	<0.001
Hs-CRP (mg/L)	1.31 (1.21-1.45)	0.04	2.22 (1.41-2.36)	0.003	2.53 (1.79-3.70)	0.001	3.57 (1.65-7.29)	<0.001
SDF-1α (ng/L)	0.95 (0.65-1.27)	0.74	1.20 (0.31-2.03)	0.70	1.01 (0.52-2.76)	0.30	0.83 (0.65-1.27)	0.76
SOD3 (U/mL)	1.20 (0.75-1.69)	0.25	1.31 (0.83-1.90)	0.17	1.58 (0.86-2.47)	0.08	1.24 (0.69-2.13)	0.28
eNOS (pg/mL)	1.32 (0.53-2.54)	0.31	1.46 (0.72-1.49)	0.09	1.73 (0.64-3.01)	0.14	1.53 (0.75-2.19)	0.13

SOVS: severe one-vessel stenosis; OVO: one-vessel occlusion; TVO: two-vessel occlusions; MVO: multivessel occlusions.